David Will - 03 Mar 2025 Form 4 Insider Report for Chemours Co (CC)

Reporting relationship: Chief Accounting Officer
Issuer ticker: CC
Reported as of: 03 Mar 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 05 Mar 2025, 20:44:47 UTC
Prior SEC filing: 13 Aug 2024
Next SEC filing: 14 Aug 2025
Source filing: View source filing
Reporting owner signature: /s/ Kristine Wellman, Attorney-in-Fact

Key filing fact

David Will filed Form 4 for Chemours Co (CC) on 05 Mar 2025.

Key facts

This page summarizes David Will's Form 4 filing for Chemours Co (CC).
3 reported transactions and 2 derivative rows are listed below.
Accepted by SEC: 05 Mar 2025, 20:44.

Change

Previous filing in this sequence was filed on 13 Aug 2024.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CC transaction

Common Stock

Award

Transaction value: $0
Shares: +5,411
Change %: +26%
Price: $0.000000
Shares after: 26,395
Date: 03 Mar 2025
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CC transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +17,985
Change %
Price: $0.000000
Shares after: 17,985
Date: 03 Mar 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 17,985
Exercise price: $13.86
Footnotes: F2

CC transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +18,704
Change %
Price: $0.000000
Shares after: 18,704
Date: 03 Mar 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 18,704
Exercise price: $15.25
Footnotes: F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Restricted Stock Unit award scheduled to vest in three equal annual installments beginning on March 1, 2026.

Footnote F2

These options are scheduled to vest in three equal annual installments beginning on March 3, 2026.

Footnote F3

Represents a 10 percent premium above the closing price of the Company common stock on the date of grant.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .